Impaired trunk stability in individuals at high risk for Parkinson's disease

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Maetzler, Walter ^a,b,c   Mancini, Martina ^d   Liepelt Scarfone, Inga ^a,b   Müller, Katharina ^a,b   Becker, Clemens ^c   van Lummel, Rob C ^e   Ainsworth, Erik ^e   Hobert, Markus ^a,b   Streffer, Johannes ^f   Berg, Daniela ^a,b   Chiari, Lorenzo ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e McRoberts BV   (Netherlands)

^f JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELEROMETER; ADULT; ARTICLE; BALANCE IMPAIRMENT; BODY EQUILIBRIUM; BODY HEIGHT; BODY MASS; BODY POSTURE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PARKINSON DISEASE; SCORING SYSTEM; STANDING; TRUNK; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS; TORSO;

EID: 84858785464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032240     Document Type: Article

References (36)

1. Maetzler W, Liepelt I, Berg D, (2009) Progression of Parkinson's disease in the clinical phase: potential markers. Lancet Neurol 8: 1158-1171.
2. Hoehn MM, Yahr MD, (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
3. Beuter A, Hernandez R, Rigal R, Modolo J, Blanchet PJ, (2008) Postural sway and effect of levodopa in early Parkinson's disease. Can J Neurol Sci 35: 65-68.
4. Chastan N, Debono B, Maltete D, Weber J, (2008) Discordance between measured postural instability and absence of clinical symptoms in Parkinson's disease patients in the early stages of the disease. Mov Disord 23: 366-372.
5. Mancini M, Horak FB, Zampieri C, Carlson-Kuhta P, Nutt JG, et al. (2011) Trunk accelerometry reveals postural instability in untreated Parkinson's disease. Parkinsonism Relat Disord 17: 557-562.
6. Frenklach A, Louie S, Koop MM, Bronte-Stewart H, (2009) Excessive postural sway and the risk of falls at different stages of Parkinson's disease. Mov Disord 24: 377-385.
7. Lees AJ, (1992) When did Ray Kennedy's Parkinson's disease begin? Mov Disord 7: 110-116.
8. Mirelman A, Gurevich T, Giladi N, Bar-Shira A, Orr-Urtreger A, et al. (2011) Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann Neurol 69: 193-197.
9. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583-590.
10. Ebersbach G, Gunkel M, (2010) Posturography reflects clinical imbalance in Parkinson's disease. Mov Disord 26: 241-246.
11. Postuma RB, Gagnon JF, Montplaisir J, (2010) Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry 81: 1008-1013.
12. Stern MB, Siderowf A, (2010) Parkinson's at risk syndrome: can Parkinson's disease be predicted? Mov Disord 25 (Suppl 1): S89-93.
13. Lang AE, (2011) A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 26: 775-783.
14. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR, (2003) Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18: 414-418.
15. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, et al. (2008) Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 63: 167-173.
16. Berg D, Seppi K, Behnke S, Liepelt I, Schweitzer K, et al. (2011) Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 68: 932-937.
17. Liepelt I, Behnke S, Schweitzer K, Wolf B, Godau J, et al. (2011) Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population. Neurobiol Aging 32: 1599-1606.
18. Berg D, Seppi K, Liepelt I, Schweitzer K, Wollenweber F, et al. (2010) Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly. Mov Disord 25: 1464-1469.
19. Postuma RB, Gagnon JF, Vendette M, Montplaisir JY, (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain 132: 3298-3307.
20. Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, et al. (2012) Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study. Mov Disord Epub ahead of print.
21. Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR, (2012) Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. Parkinsonism Relat Disord 18 (Suppl 1): S199-202.
22. Appel-Cresswell S, de la Fuente-Fernandez R, Galley S, McKeown MJ, (2010) Imaging of compensatory mechanisms in Parkinson's disease. Curr Opin Neurol 23: 407-412.
23. Palmer SJ, (2010) Compensatory mechanisms in Parkinson's disease Vancouver University of British Columbia.
24. Hughes AJ, Daniel SE, Kilford L, Lees AJ, (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
25. Marder K, Tang MX, Mejia H, Alfaro B, Cote L, et al. (1996) Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 47: 155-160.
26. Hummel T, Konnerth CG, Rosenheim K, Kobal G, (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110: 976-981.
27. Moe-Nilssen R, (1998) Test-retest reliability of trunk accelerometry during standing and walking. Arch Phys Med Rehabil 79: 1377-1385.
28. Moe-Nilssen R, (1998) A new method for evaluating motor control in gait under real-life environmental conditions. Part 2: Gait analysis. Clin Biomech (Bristol, Avon) 13: 328-335.
29. Bottaro A, Casadio M, Morasso PG, Sanguineti V, (2005) Body sway during quiet standing: is it the residual chattering of an intermittent stabilization process? Hum Mov Sci 24: 588-615.
30. McVey MA, Stylianou AP, Luchies CW, Lyons KE, Pahwa R, et al. (2009) Early biomechanical markers of postural instability in Parkinson's disease. Gait Posture 30: 538-542.
31. Baldinotti I, Timmann D, Kolb FP, Kutz DF, (2010) Jerk analysis of active body-weight-transfer. Gait Posture 32: 667-672.
32. Bloem BR, Beckley DJ, van Dijk JG, Zwinderman AH, Remler MP, et al. (1996) Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease. Mov Disord 11: 509-521.
33. Palmerini L, Rocchi L, Mellone S, Valzania F, Chiari L, (2011) Feature selection for accelerometer-based posture analysis in Parkinson's disease. IEEE Trans Inf Technol Biomed 15: 481-490.
34. Yan JH, Dick MB, (2006) Practice effects on motor control in healthy seniors and patients with mild cognitive impairment and Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 13: 385-410.
35. Nicolai S, Mirelman A, Herman T, Zijlstra A, Mancini M, et al. (2010) Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy. Z Gerontol Geriatr 43: 224-228.
36. Allum JH, Tang KS, Carpenter MG, Oude Nijhuis LB, Bloem BR, (2011) Review of first trial responses in balance control: influence of vestibular loss and Parkinson's disease. Hum Mov Sci 30: 279-295.